Biofrontera Inc.
BFRI
$0.72
-$0.0674-8.56%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.76M | -12.84M | -13.51M | -23.09M | -20.13M |
| Total Depreciation and Amortization | 1.15M | 1.22M | 1.16M | 1.11M | 1.06M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 128.00K | -7.36M | -6.15M | 586.00K | -1.43M |
| Change in Net Operating Assets | 6.21M | 856.00K | -421.00K | -3.13M | -4.39M |
| Cash from Operations | -10.27M | -18.12M | -18.92M | -24.53M | -24.90M |
| Capital Expenditure | -10.00K | 0.00 | 0.00 | -48.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.00K | 71.00K | 453.00K | 681.00K | 624.00K |
| Cash from Investing | -3.00K | 71.00K | 453.00K | 633.00K | 619.00K |
| Total Debt Issued | 4.05M | 11.70M | 19.55M | 25.25M | 25.25M |
| Total Debt Repaid | -4.32M | -13.81M | -20.77M | -23.21M | -21.34M |
| Issuance of Common Stock | 15.10M | 19.61M | 19.61M | 12.17M | 4.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.84M | 17.50M | 18.39M | 14.21M | 8.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.56M | -549.00K | -74.00K | -9.69M | -15.87M |
